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Background:  The number of visitors to Tibet has been increasing recently and reached to 
more than six million in 2010. Many of the tourists are not aware of the risk of altitude 
sickness. The most common altitude sickness to high altitude visitors is acute mountain 
sickness (AMS), which is unpleasant and may progress to the life threatening condition of 
high altitude cerebral oedema (HACE) and high altitude pulmonary oedema (HAPE). These 
problems are of public concern as they have health implications for the health authorities and 
economic implications for tourism industry in Tibet. Yet, so far no research on acute 
mountain sickness among tourists has been conducted in Lhasa.  
Aim: The study aims to estimate AMS prevalence among tourists and its various subgroups in 
Lhasa.   
Methods: A cross-sectional study was conducted among 2385 tourists in Lhasa who were 
above the age of 15 years. The participants were recruited in the randomly selected hotels in 
Lhasa during the time of the study was carried out between the 2nd of June and the 31st of 
October 2010. The Lake Louise Score System (LLSS) was used to assess AMS. Both English 
and Chinese version of LLSS-based questionnaire was used for data collection.  
Results: AMS prevalence was 50.8% in total sample and 44% in subset two hotels’ sample. 
The AMS prevalence was higher among participants without previous experience of high 
altitude than with the experience and, in people aged between 20 and 60 as compared with 
those younger or older and it was more often found in men than in women. The AMS was 
more common among participants, who arrived in Lhasa by air, who took medication for 
preventing AMS before coming to Tibet and pain-relieving medication after they arrived in 
Tibet, and among those who have had previous experience AMS symptoms. 
Conclusion:  The estimated prevalence of AMS among tourists in Lhasa is high and lies 
between 44%–50.8% using the LLSS AMS diagnostic standards (headache plus one other 
symptoms and LLSS≥ 3).  The prevalence of AMS was significantly higher in people who 




A large and increasing number of tourists are travelling to Tibet (2) and other high altitude 
areas around the world; many without knowing about the risk of developing acute mountain 
sickness (AMS). In Tibet nowdays international and domestic tourists as well as  immigrants 
of Han Chinese origin and their family and friends constitute risk groups for the development 
of AMS. Lhasa, one of the world’s highest cities, and the capital of Tibet Autonomous Region 
(TAR), is the first destination of most vistors to Tibet. Knowledge about the prevalence of 
AMS among these visitors is of importance for planning of health services. Furthermore, 
knowledge about risk factors and protective measures for AMS will help the health authorities 
in Tibet to provide the best advice and treatment for immigrants and visitors. Health personell 
in general, locally and abroad, may utilise such knowledge to inform tourists who plan to 
travel to high altitude areas.  
AMS is known as a combination of non-specific symptoms like gastrointestinal symptoms 
(loss of appetite, nausea, or vomiting), headache, insomnia, dizziness, and lassitude or fatigue, 
but without abnormal neurological findings (3;4). Altitude level, speed of ascent, and 
individual susceptibility, awareness, general state of health, age, gender, and obesity have 
been found to be associated with AMS (3-6). AMS is largely preventable and most AMS 
patients recover after simple treatment. However, some cases may progress to high-altitude 
cerebral edema (HACE) and high-altitude pulmonary edema (HAPE),  which are life 
threatening (4;7).  
Studies of the prevalence on AMS among tourists, trekkers, railway construction workers, and 
army populations have been carried out in many other countries and areas (8-22). With an 
altitude of 3649 meters above sea level and located the north face of  Mt. Everest in the 
Himalayas, the altitude and climate in Lhasa is a challenge to tourists. Another challenge for 
most visitors is to Tibet’s main city of culture and religion, Lhasa is that certaion ways of 
travell to Tibet do not allow for gradual acclimatition. Most go by plane directly to Lhasa. 
Going by railway gives a slightly more gradually ascent as it take about 30 hours from the last 
low land station to Lhasa. Compared to research among army members and trekkers 
(15;20;23), tourists in Lhasa are more heterogenous group, constituting of people of different 




Prior to the current study, two Norwegian students from Medical Faculty of Oslo University 
(UiO), conducted a pilot study of AMS among 30 subjects in Lhasa in the early spring in 
2008 (24). The pilot offered important information for the planning of the current study. 
The present cross-sectional study aims at giving the prevalence of AMS among the study 
population of tourist and its various subgroups in Lhasa.  
CHAPTER II   INTRODUCTION 
 
1. General information about Tibet 
The three major high-altitude regions in the world are the Himalayas in Asia, the Andes South 
America and the Rocky Mountains in North America. The Himalayans and its northern 
Tibetan plateau, where the research site is located, is the highest and largest high altitude 
plateau in the world. Altitude divided by levels according to their sea level is as follow (5;25):  
a. Intermediate: 150–2500 m (4921–8202 ft.);  
b. High: 2500–3500 m (8202–11483 ft.); 
c. Very high: 3500–5500 m (11483–18045 ft.); 
d. Extreme: 5500–8850 m (18045–29035 ft.) or more.  
1) Tibet  
Tibet, in Tibetan is called “bod” and in Chinese “Xizang”. This can refer to all three 
traditional parts of Tibet, including U-Tsang, Amdo and Kham. Only U-Tsang is what 
corresponds to Tibet Autonomous region (TAR) today, established in 1965, while other areas 
of Tibet today are part of the four provinces of Qinghai, Sichuan, Gansu and Yunnan. In this 
thesis I will use the term Tibet interchangeably with the TAR.  Tibet features an average 
elevation that exceeds 4900 m (16000 ft) (26), and has therefore often been called the “Roof 
of the World”. The south and the west of the plateau bordered the mighty Himalayas and to 
the north the Kun Lun Mountains. Covering an area of 1.22 million square kilometres, the 
TAR is divided into one city and seven prefectures. These are Lhasa city, and the prefectures 
of Nagchu, Chamdo, Nyingtri, Lhoka (also called Shannan), Shigatze and Ngari (Figure 1).  
According to the 2010 national census, the TAR has more than three million (3,002,166) 
inhabitants and most of them are Tibetans (90.48%)(27),  8% of inhabitants are Han Chinese 
(27). Tibetan and Mandarin Chinese are the main languages used in TAR and the dominant 
religion is Tibetan Buddhism.  
The economy of Tibet is still largely based on agricultural subsistence, though there are vast 
pastoral regions as well. Tourism has become a growing industry in Tibet in recent decades 
and it is planned to be one of the main industries in Tibet  (28;29).  
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2) Lhasa 
Lhasa (“Lhasa”in Tibetan and “Lasa 拉萨”in Chinese) is the capital of TAR. It is located 
on the northern bank of the Kyichu River (also called Lhasa River), a tributary of the Yarlung 
Tsangpu River (also called Brahmaputra). The city was founded 1300 years ago, and covers 
30000 square kilometres, with a central area of 544 square kilometres. The estimated 
population in 2010 was 559,423 (27). The elevation of Lhasa at 3649 meters above sea level 
makes it one of the highest cities in the world. The average yearly temperature is 8.5° C, and 
Lhasa has an annual average of 3021 hours of sunlight. Lhasa has acted as the centre of 
Tibetan politics, economy, culture, transport and it is an extremely important and sacred site 
for Tibet’s Buddhism. Lhasa contains many culturally significant Tibetan Buddhist sites such 
as the Potala Palace, Jokhang and Norbulingka Palace. 
Lhasa city consists of Chengguan district, which equals urban Lhasa and seven small counties: 
Lhündrup, Damshung, Nyemo, Chuchul, Thölung, Taktse and Medrogongkha counties. The 
central and urban part of Lhasa, also called Chengguan District, is the location of the 
administration of the prefecture and the whole of the TAR. The largest airport of TAR is 
situated about one hour drive outside Lhasa, and Lhasa features the terminal station of the 
Qinghai-Tibet railway as well as the Qinghai-Tibet, Sichuan-Tibet and Yunnan-Tibet 
motorways (Figure 2). 
3) Health care facilities in Lhasa 
In Tibet, the general standard of hospitals is still not very high, but treatment of altitude 
sickness can be sought in several health care facilities in Lhasa. There are three high level 
hospitals: The ‘First TAR People’s Hospital’ which has an emergency treatment center for 
altitude sickness; ‘TAR People's Liberation Army General Hospital’ with an high altitude 
research center; and the Department of Respiratory Disease at the ‘TAR Armed Police 
General Hospital’. Some mid-level hospitals such as the ‘Second TAR People’s Hospital’; an 
affiliated hospital of the ‘Tibetan Medical and Astrological Institute’ (“Mentsikhang” in 
Tibetan); and the ‘Lhasa City People’s Hospital’ also have the ability to treat mild and 
moderate forms of AMS.  Two private hospitals and a number of private clinics provide 
oxygen and other medication for the treatment of AMS. 
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 Figure 1. The location of Lhasa in TAR (Adapted from China tour. 
http://www.chinamandarintours.com/china-guide/Tibet/) 
 
Figure 2. Map of main roads to Lhasa (The Qinghai-Tibet  Railway line along with Qinghai-Tibet Highway. Adapted from 
Dreams Travel Tibet & Sichuan.: http://english.dreams-travel.com/guide/tibet/map_tibet2.htm) 
 
4) Tourism in Tibet (Lhasa) 
Tibet, with its fantastic and spectacular landscapes and unique cultural characteristics, has 
become popular a tourist destination. In terms of changing travel habits, politics, economy 
and development of the railway to Lhasa in 2006, the city has recently become a major 
destination for what one could call ‘ordinary’ travellers, such as immigrants from the 
lowlands, especially from inland China, and their family and friends who come to visit them. 
According to surveys by the National Statistical Bureau of China, the number of tourists from 
mainland China and abroad to TAR has increased sharply from approximately 690,000 in 
2001 to 4,020,000 in 2007 and to more than 6 million in 2010 (30) (Figure 3). Based on the 
Tourism Development Plan for the TAR of the year 2008, the the government authorities are 
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planning a remarkable growth in tourism to the region, with a goal of 10 million visitors in 
total, 9 million from China and 1 million from abroad by 2020.  
 
Figure 3.  The number of tourists in Tibet 1980s- 2020 (by million) 
( Data available from National Statistic Bureau of China(www.stats.gov.cn) and Tibetan tourism development masterplan 
(Beijing Daily: www.bjd.com.cn on 10 June,2005) 
Hotels, lodges and guesthouses are crucial facilities for any tourism industry. In Tibet, the 
number of hotels is increasing. Most tourist facilities in Tibet are located in Lhasa. In the city 
of Lhasa, there are a number of guest houses and 90 star-rated hotels  (31).  
 
2. Acute mountain sickness 
1) Definitions of AMS 
Acute mountain sickness (AMS) is a common affliction in otherwise healthy people who 
ascent rapidly to high altitude areas. According to the Lake Louise Consensus on AMS, 
arrival of a person who is not used to altitudes of more than 2000 meters above sea level and 
reaches there may experience a combination of non-specific symptoms including headache, 
gastrointestinal symptoms (loss of appetite, nausea, or vomiting), insomnia, dizziness, and 
lassitude or fatigue (4;6;25;32), but without abnormal neurological presentation (3). The 
symptoms typically develop within six to ten hours (32) between six and twelve hours (4) 
after ascent, and sometimes even as early as within one hour (32). The symptoms mentioned 
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above are usually most pronounced on the second or third day (5), and they often disappear 
by fifth day. In serious cases AMS will progress to high-altitude cerebral edema (HACE) and 
high-altitude pulmonary edema (HAPE) which are much less frequent than AMS, but are 
potentially fatal (4).  
There is no golden standard in the form of a biological marker for the diagnosis of AMS. 
Several definitions and different scoring systems of AMS have been developed in order to 
measure AMS. These are based on subjective reports of typical symptoms, and possibly a 
physical examination by health professionals who have good knowledge of altitude sickness. 
Questions about symptoms can be recorded either through self-reporting forms, or by an 
investigator. Prevalence of AMS is confirmed if AMS scores exceed a defined limit. Clearly 
defined scoring systems make it possible to compare results from different studies if identical 
methods are applied. 
The Lake Louise Scoring System (LLSS) (3) and the The Environmental Symptoms 
Questionnaire (ESQ) (33) are used most comonly and are recommended (1). There exist also 
ohter AMS scoring systems like the Hackett’s Questionnaire (34) and the Chinese ad hoc 
‘high altitude medical research questionnare’ (HAMRQ) (20). 
The so-called ‘Hackett Questionnaire’ (34)was developed for the surveys Hackett carried out 
in the 1970s in order to map AMS. It consists of a brief structured interview about headache, 
nausea, vomiting and dizziness. In addition, it includes a 
physical examination on edema, respiratory rate, lung 
and ataxia. The diagnosis of AMS according to Hackett 
is based on a combination of the results of the interview 
scores and the physical examination (35). Review of 
recent literature shows that only few studies use 
Hackett’s AMS system. 
The Environmental symptoms questionnaire (ESQ) 
The Environmental Symptoms Questionnaire (ESQ) was 
developed in the early 1980s (1). The purpose was to create a standardized system to assess 
symptoms that soldiers experienced in extreme environments (36). The questionnaire has 
since then been revised and the current version is the third version (ESQ-III). It consists of 67 
questions, but only eleven are relevant for assessing AMS (Table 1). The answers are rated 
from zero (not present) to five (extremely severe), but are weighted in a special manner when 
Table 1. Eleven Questions of the ESQ-
III pertaining to Altitude Sickness. 
1. I feel lightheaded  
2. I have a headache  
3. I feel dizzy  
4. I feel faint  
5. My vision is dim  
6. My coordination is off  
7. I feel weak  
8. I feel sick to my stomach  
9. I lost my appetite  
10. I feel sick  
11. I feel hung over  
Source: Dellasanta et al., 2007 (1). 
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the aim is to assess AMS (using an assigned factor numbers). To assess whether a person has 
AMS or not, one must calculate a score called AMS-C (C stands for cerebral symptoms). To 
obtain the AMS-C score, the sum of all item scores multiply by the respective factorial weight, 
and are then multiplied by five and divided by 25.95. In ESQ-III, AMS is defined if the AMS-
C ≥ 0.7.  
ESQ -III can be either administered by an investigator, or could be used in the form of a self-
report form. Both thoese methods have been shown to give equally good results. In addition, a 
recent study (37) has been conducted to compare the 67 questions and an electronic version 
containing only the eleven questions that are relevant to altitude sickness. It shows that there 
is significant agreement between the two versions, and concludes that the online short version 
can be used in place of the full version, when studying the prevalence of AMS (37). 
Lake Louise score system (LLSS) 
At a scientific conference (the ‘International Symposium on hypoxia’) at Lake Louise, 
Canada, in 1991, an agreement was reached on a simpler questionnaire than the one 
previously used but also one that would be more complex than the above-mentioned 
‘Environmental Symptoms Questionnaire’ (ESQ).  Adjustments were made at the next 
conference in 1993. The Lake Louise Consensus Group describes an AMS self assessment, 
which can be supplemented by a clinical assessment and a functional score (37;38) (Table 2). 
The LLSS “is based on the quantification of the reported subjective sensation of the severity 
of symptoms” (33).  It can be self-reported or used in combination with a clinical assessment.  
Lake Louise AMS self assessment consists of only five questions (Table 2). These are based 
on the most common symptoms of AMS: headache, gastrointestinal upset, insomnia, 
weakness or fatigue, and dizziness or lightheadedness. There are four alternative answers to 
each question. When the responses are analyzed, there will be zero, one, two or three points to 
each question. A complete response will be an AMS self-reporting scores from zero to fifteen. 
According to the Lake Louise Consensus Group, AMS is defined as the presence of headache 
in an unacclimatized person who has recently arrived at an altitude above 2500 m, and the 
presence of one or more of the following: gastrointestinal symptoms (anorexia, nausea, or 
vomiting), insomnia, dizziness, and lassitude or fatigue. Accodring to the Lake Louise Score 
System, there have to be at least two of these symptoms present (38).  
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Table 2. Lake Louise Score System (LLSS) for the diagnosis of acute mountain sickness (AMS)  
(a) AMS self assessment                                                                                                                                        
(A rise in altitude within the last 4 days and presence of headache. In addition there has to be the  
presence of at least one other symptom and a total score of three or more from the questions 
below.) 
                               Symptom Score    Question 
  0 None at all  
  1 Mild headache  
  2 Moderate headache  
 
Headache  
3 Severe headache, incapacitating  
  0 No gastrointestinal symptoms  
  1 Poor appetite or nausea 
  2 Moderate nausea or vomiting 
 
Gastrointestinal symptoms  
3 Severe nausea or vomiting, incapacitating 
  0 No tired or weak 
  1 Mild fatigue/weakness 
  2 Moderate fatigue/weakness 
 
Fatigue and/or weakness  
3 Severe fatigue/weakness, incapacitating 
  0 No dizzy 
  1 Mild dizziness 
  2 Moderate dizziness 
 
Dizziness/light-headedness 
3 Severe dizziness, incapacitating 
  0 Slept as wee as usual 
  1 Did not sleep as well as usual 
  2 Weak many times, poor night’s sleep 
 
Difficulty in  sleeping  
3 Could not sleep at all 
(b) Clinical assessment   
  0 No change  
  1  Lethargy/lassitude  
  2  Disorientated/confused  
  3 Stupor/semiconscious  
 
Change in mental status  
4 Coma  
  0 None  
  1 Balancing manoeuvres  
  2 Steps off the line  
  3 Falls down  
 
Ataxia (heel/toe walking) 
4 Unable to stand 
  0 None  
  1 One location  
 
Peripheral edema 
2 Two or more locations  
(c) Functional score                                                                                                                                               
(An optional question can be either by check or by self-report section.) 
  0 Not at all  
  1 Mild reduction 
  2 Moderate reduction  
 
Overall, if you had any of these symptoms, 
how did they affect your activities?  
3 Severe reduction (e.g. bedrest) 





The Chinese scoring system 
The Chinese Medical Association developed the so-called Ad Hoc ‘High Altitude Medical 
Research Questionnare’ (HAMRQ) based on the LLSS in 1995 (Table 3), which was adjusted 
in 1996 (20). In the Chinese scoring system, ‘acute mild high altitude disease’ (AMHAD) is 
equivalent to AMS in LLSS. The degree of AMHAD based on HAMRQ is given as the 
“Severity of Acute Mountain Sickenss” (Table 3). For instance, mild AMS is diagnosed as the 
presence of headache or vomiting that affect the functioning of daily activities. When either 
symptom is absent, a score between five and ten is required for the diagnosis of mild AMS, 
with one score assigned for each of the following symptoms: dizziness/light-headedness, 
nausea, palpitation, shortness of breath, chest tightness, dazzling/blurredvision, sleeplessness 
(insomnia), anorexia, abdominal distension, diarrhea, constipation,cyanosis of the lips, 
lethargy, and numbness of the extremities  (39).   
Table 3. The Chinese acute mountain sickness scoring system 
(a) Acute Mild High Altitude Disease (AMHAD) Scoring System      
Symptoms  Severity Score
No headache, no suffering expression, no effect on daily activity. ± 1 
Mild headache with suffering expression; obvious improvement of headache 
after taking regular analgesic medicine; no effect on daily activity. + 2 
Moderate headache with suffering expression; slight improvement of 





Severe and unbearable headache; lie in bed and cannot get up; no effect of 
regular analgesic medication. +++ 7 
 
Vomiting 1 to 2 times a day; vomit contains only intake food; obvious 
improvement with regular anti vomit medication; no effect on daily 
activity.  
+ 2 
Vomiting 3 to 4 times a day; final vomit contains gastric juice; slight 






Vomiting more than 5 times a day; must lie in bed and cannot get up; no 





Dizziness/light-headedness, nausea, palpitation, short breath, chest distress, 
dazzling/blurred vision, sleeplessness (insomnia), anorexia, abdominal 
distension, diarrhea, constipation, cyanosis of the lips, lethargy, and 
numbness of the extremities 
 
+ 1 point each
(b)Severity of Acute Mountain Sickness      
Severity   Scoring      
Normal (±)  1 to 4     
Mild (+)  Headache (+) or vomiting (+) or total score 5 to10    
Moderate (++) Headache (++) or vomiting (++) or total score 11 to 15    
Severe (+++)  Headache (+++) or vomiting (+++) or total score >16  




Summary of the definition 
HAMRQ is used by some Chinese scholars (20;22) and articles with HAMRQ were also 
recently published in western scientific journals. They argued that it is more inclusive and less 
subjective than LLSS (20). However, according to a recent debate on headache and AMS, the 
three scientists Robert Roach, Peter Hackett and Bengt Kayser assessed the Chinese scoring 
system to be in the same category with EQS (40). 
Although LLSS provides an AMS diagnostic standard, various other definitions of AMS are 
used in the scientific literature: some define AMS as a conditions that needs to present witjh 
more than the three symptoms required by LLSS (11;41), others, such as Maggiorini, defines 
AMS as an ailment of more than two LLSS symptoms among Alpine mountaineers (15) (For 
more details,  see Table 4 and 5). 
Overall, ESQ-III is more complicated than LLSS. LLSS main questions are similar to 
Hackett’s Questionnaire. According to the literature and, since the 1991 Lake Louise 
consensus on AMS, most  researchers use LLSS or LLSS based questionnaires.  
 
2) Epidemiology of AMS 
Incidence or prevalence? 
The terms and concepts of AMS ‘incidence’ or ‘prevalence’ are used interchangeably in AMS 
related literature. Hardly any article discusses which one of the two would be preferable to 
describe the currency of AMS.  
Prevalence is a frequently used epidemiological measure to describe the total number in a 
defined population afflicted with a particular disease or condition. This is further specified 
and described when occurring at a stated point in time as the so-called ‘point prevalence’, 
when occurring during a given period of time as ‘period prevalence’, or if the condition has 
occurred during the life time, it is named ‘life time prevalence’. Point prevalence is usually 
expressed as a rate, the denominator being the number of persons in the specified population 
at that point of time (42). For example, AMS questionnaires were distributed among 200 
tourists who lived in the Old Mandala Hotel in Lhasa in July, 2010. 100 tourists out of 200 
had AMS, i.e. the AMS prevalence in Old Mandala Hotel was 50%. 
Incidence is another concept usually used when measuring the rate of occurrence of new cases 
of a disease or condition over a defined span of time in a specified population. Incidence may 
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be expressed as the cumulative incidence, the denominator being the average number of 
persons in the specified population during the defined period or the estimated number of 
persons at the mid-point of that period who present a certain condition or disease (42). For 
example, 10000 people who had just arrived in Lhasa were followed during my study for four 
days. 250 out of the group were diagnosed with AMS during those four days, i.e. the 
incidence of AMS among this group in Lhasa was 250 per 1000 that is 25%. Incidence may 
also be expressed as the incidence rate which is the number of new cases divided by the total 
number of people followed over a defined period of time. 
Incidence and prevalence are different, yet related. Prevalence means about the same as 
incidence, but is multiplied by the disease duration. For diseases that last for a long time or 
chronic diseases, such as cardiovascular disease or diabetes, the prevalence is significantly 
higher than incidence. For diseases that last only a short time, such as colds, prevalence is 
approximately equal to incidence. Therefore, for acute diseases like AMS, prevalence equals 
incidence (43).  
Prevalence of AMS in global comparison 
The prevalence of AMS among adults varies between 3% and 93% in studies conducted at 
different altitude levels applying different methods (4;10;25;44). Studies on AMS in trekkers, 
army, railway construction workers and tourists have been done in America, Europe, Asia, 
Africa and New Zealand (8-22) (Figure 4).  
Table 4 shows estimated prevalences of AMS among tourists in North American Rocky 
Mountains, the Nepalese Himalayas, in Hawaii, in La Paz,  Bolivia and inTibet.  
Honigman et al. examined the prevalence of acute mountain sickness among tourists in the 
Rocky Mountains, Colorado in 1993 (11). The authors pointed out that their study was the 
largest study of tourists traveling to moderate altitudes. The study populations were the 
attendees of various conferences around Colorado. During a two-year period, a total of 4212 
adults took part in their studies. They were recruited from 45 conference hotels situated 
between 1920 and 2950 meters above sea level. The questionnaires were distributed to 
participants of conferences within 48 hours after arrival. Brief information about the study 
project was given and questionnaires were collected later in the same resort. A Total of 3158 
questionnaires (75%) were completed. 
AMS was defined as the presence of three or more LLSS symptoms. 25% percent of 
conference attendees developed AMS, and of them, 65% within the first twelve hours after 
 Tibet,  tourist, army 
4719 m 1days 42.3%AMS 
3600 m  14days 57.2% 
AMS 1.9%HAPE 
Kilimanjaro  2743m 
3% 4730m 47% AMS 
Figure 4.  Global acute mountain sickness incidence reports.(Adapted from Gallagher SA, Hackett PH. High-altitude illness (5). Additional data on Tibet and 
Kilimanjaro site. (14;20;44).  
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arrival. Of those with symptoms, approximately half reduced their physical activity. The 
prevalence of AMS was higher among those with permanent residence under 914 meters, 
previous AMS experience and lung disease, and in the attendees of young age, as well as 
among women and those with poor or average physical condition. 
According to the study of Hochedez et al. 2004 (45), the prevalence of AMS was reported for 
the years 1984 and 2001 among French Travelers to Nepal. 50% of these, who visited a 
doctor at the French Embassy in Kathmandu in 2001, had symptoms of altitude sickness as 
compared with no altitude sickness cases reported in 1984. Another study conducted in 1986 
by Bengt Kayser (23) among 530 western trekkers visiting  the Thorong pass in Nepal 
(5400m above sea level) showed that 63% had AMS according to the definition of AMS by 
ESQ-III.  
The Survey of AMS on Mauna Kea,Hawaii (19), a 4200 meters high volcano tourist attraction 
reported a prevalence of 30% among day visitors and 69% professional astronomy staff. It 
takes less than two hours to drive to the peak. In a two-day data collection, approximately 350 
English-speaking tourists were handed questionnaires along the road up to the top of the 
vulcano. The forms were then returned at a collection point, or submitted by mail afterwards. 
A total of 198 questionnaires was collected. In this study ASM was defined as a per LLSS 
standards, i.e. more than two of the symptoms of AMS, in addition to the presence of  
headache and of one other symptom. 
Carlsten et al. conducted a study in La Paz Bolivia located at 3630 m (46), a city at similar 
altitude to Lhasa, Tibet. The study’s primary aim was to determine the effect of acetazolamide 
as a prophylaxis for AMS. Immediately after participants’ arrival in La Paz,  32 individuals 
were included in the study and nine of them had AMS. AMS was defined accoring to Lake 
Louise Symptom Score (i.e. more than two symptoms).  
One AMS study has been carried out among tourists in Tibet. It was conducted by a Chinese 
Master’s student in 2008 at  the Namtso Lake Tour Zone (4,718 m) and among 310 one-day 
Chinese tourists (14). It reported an AMS prevalence of 42.3% used LLSS. Furthermore, 82% 
of participants who suffered from AMS experienced the onset of AMS symptoms within the 
first hour of arrival at the altitude of the study area.  
In addition to this study there are two recent articles in international journal. One is a study of 
AMS in Qinghai-Tibet railway construction workers (22). In this article Wu and colleagues 
broadly discuss AMS based on data from 14,050 workers of the world’s highest railway 
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construction project. The railway goes from Golmud (2808 m) to Lhasa (3649 m) and in total 
is 1142 km long.  85% percent of the railway is situated above 4000 meters and its highest 
point is the Tanggula Pass at 5072 meters. The construction of the railway was completed at 
the end of 2005 and the study had taken four and half years to be completed. 
The study reports that 80% of the workers had been born and raised in the lowlands (below 
760 meters) and had never been exposed to high altitude in the past.  
The workers were mainly men (98.8%), aged 20 to 62 years. Prior to signing contracts by the 
workers, the researchers had undertaken a health screening for all workers. Contraindications 
for employment were screened for hypertension (systolic ≥ 160 and / or diastolic ≥ 95); 
certain forms of arrhythmia; angina pectoris; certain ECG findings; diabetes; ulcers; chronic 
liver disease; COPD; pregnancy; and epilepsy. To allow a better acclimatization for all 
workers from the lowlands, the ascent to the plateau took place gradually over eight days 
before their work shift started. All workers were advised to avoid hard physical activity the 
first week after arrival at altitude. 
Questionnaires were completed between two and three hours after the first arrival of the 
workers at the construction site and then every night before sleeping for eight weeks. To 
determine the prevalence of AMS, the Lake Louise questionnaire was used, and AMS was 
defined as a score of ≥ 3 symptoms and the presence of headache. According to the study, the 
prevalence of AMS was 51% on initial exposure, that of HACE 0.3% and HAPE 0.5%. The 
prevalence among people with obesity is shown to have been much higher than in people with 
normal BMI. 
Another AMS study was conducted in Tibet by Ren Yi. et al. in 2009 (20). The study was 
carried out among Chinese soldiers who arrived to in Tibet at an altitude of 3600 meters. The 
study investigated 3628 unacclimatized soldiers who have never been exposed to high 
altitudes and who arrived by air. The Chinese Ad Hoc High Altitude Medical Research 
Questionnaire (HAMRQ) was used for the data collection. The data were collected two weeks 
after the arrival. Physical examination and appropriate laboratory tests were also performed 
for hospitalized subjects. 2063 (57.2%) of the soldiers had mild acute mountain sickness and 
249 (12.07%) of them were hospitalized for treatment. The prevalence of HAPE was 1.9%, 
while HACE and death were not reported. Psychological stresses and excessive physical 
exertions possibly contributed to the onset of HAPE.  
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So far, there is no AMS study has been conducted among tourists or ordinary population in 
Lhasa, a major gap that this master thesis is aimed to address. 
 
 





Whom Number Definition AMS  Time of arrival AMS prevalence 
(%)  
1  1993  Rocky Mountains, 
Colorado 
1920-2950 Conference attendees in 
45 conference hotels 
3158 ≥3 LLSS symptoms < 48 hours 25 
2  2004  Nepal Not Given All French tourists i 
Nepal in 2001 
21457 LLSS: headache and 
one of other 
symptoms 
Not Given 15 
3  1991  Nepal 5400 Trekkers to Thorong Pass 530 ESQ-III The eighth day 63% 
4  2007  Mauna Kea, 
Hawaii 
4200 Tourists 198 LLSS: headache plus 
one of other 
symptoms  and score 
at least three. 




5  2004  La Paz, Bolivia 3630 Tourists by air from 
Miami, USA 
32 LLSS: headache plus 
one of other 
symptoms  and score 
at least three. 
2 hour 28 
6  2008  Namtso Lake Tour 
Zone , Tibet 
4718 Chinese Tourists 310 LLSS: headache plus 
one of other 
symptoms  and score 
at least three. 
< 24 hour 42.3 
7  2007  Tibet +/- 4000 Railway construction 
Workers 
14050 Chinese standard: 
HAMRQ 
2-3 hours, + every 
ninght for 8 weeks 
51 
8 2009 Tibet 3600 Chinese new army to 
Tibet 
3628 Chinese standard: 
HAMRQ 
2 hours 57.2 
 
Studies: 
1. Acute mountain sicknesss in a general tourist population at moderate altitudes (11). 
2. Changes in the pattern of health disorders diagnosed among two cohorts of French travelers to Nepal, 17 years apart (45). 
3. Acute mountain sickness in western tourists around the thorong pass(5400m) in Nepal (23). 
4. Survey of Acute Mountain Sickness on Mauna Kea (19). 
5. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet 
(3630 m)  (46).  
6. An epidemiological investigation of acute mountain sickness  in tourist population in Lake NaMuCuo (Namtso) in Tibet, 
P.R.China (14). 
7. Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad  (22). 
8. Incidence of high altitude illnesses among unacclimatized persons who acutely ascended to Tibet (20). 
LLSS:  Lake Louise Scoring System 
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3) Determinants of AMS prevalence  
High altitude, fast speed of ascent, and lack of acclimation are major determinants of AMS 
susceptibility, while some studies also show an association with general states of health, age, 
gender, and obesity (Figure 5). The reason for the considerable variation in individual 
susceptibility is currently poorly  understood (3).  
 
Figure 5.  Determinants of acute mountain sickness prevalence (11;15;23) (20). 
Altitude, way and rate of ascent 
Based on the studies among Alpine mountaineers (15), in visitors to the Rocky Mountain (11), 
in trekkers in Nepal (23), and in the army in Tibet (20), prevalence of AMS increases 
progressively with altitude and with a fast rate in both active ascent, such as by foot or bicycle, 
s well as passive ascent such as by air, car or train (Table 5). Differences in prevalence 
between studies may be explained by varying definitions of AMS, differences in study 
population, mode of ascent, altitude, and activity level at altitude (Table 5). 
Pre-acclimation 
Altitude acclimatization indicates the process of adjusting to decreasing oxygen levels at 
higher elevations, in order to reduce the risk of altitude sickness (47). Previous experiences at  
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Research site  






3158 1828-2134 18 

















convenience sample  
questionnaire in English
75 Acetazolamide (11) 
47 2850 9 
128 3050 13 






Within 1 or more days 
By foot +passive 
 
52 
0.05 Swiss Alps (46) 
interview and clinical 
examination 
Questionnaire in German  
& Italian 
NG NG (15) 
20 2500-3000 0 
18 3000-3500 10 
18 3500-4000 10 
17 4000-4500 15 








0.7 Nepali Himalaya (27)
Prospective, observational 
study, convenience 
sample  Interview in 
English 
NG Acetazolamide (48) 
34.7±10.4 79 3454 38 Eastern Aples (46) Mountaineers 
or Tourists 36.8±11.6 83 
Headache, an 
additional 
symptom and a 
LLS≥ 4 3817 
By foot 
34 
NG Western Aples 
(46) 
Prospective, observational 
study, Questionnaire in 
German,English,French
about 60 NG (17) 
Trekkers NG 1066 LLSS  (LLS≥3) 3952 by foot (stepwise ascent) 36 1/1066 




study (1 year) 
Questionnaire 
NG Acetazolamide Rhodiola (21) 
New Army 18 (17-20) 3605 Chinese standard 3600 By airplane 57.2 1.9% Tibet 
Cross-sectional study  
questionnaire in Chinese 99.36 NG (20) 
Trekkers 38 353 ESQ 5400 By foot within 2-3days 63 3/530 Thorong pass in Nepal (27)
Prospective study, 
Questionnaires 70 Aspirin, Paracetamol (23) 
116 By airplane 84 21 took Acetazolamide 





≥3 symptoms 3740 
 50.8 






LLSS: Lake Louise score system;  LLS: Lake Louise score; n: the number of the people involved in the study; HACE: high-altitude cerebral edema; HAPE: high-altitude pulmonary edema; m: 
meters; NG: not given
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 high altitude prevent or ameliorate AMS symptoms on re-ascent after return to sea level 
(3;10;25). 
Age 
In adults, there is a decrease in AMS with increasing age (above 40) as reported widely 
among Himalayan trekkers (34), conference attendees  (11), and mountaineers (15). It seems 
that older people may be somewhat protected from AMS, but the reason for this is not yet 
known. In contrast to this finding, the current perception is that older people are more 
sensitive to symptoms of AMS and thus more careful about their health and less frequently 
ascend to high altitude areas. 
Gender 
Men and women seem to suffer from AMS with comparable frequency and severity. The 
incidence in men and women trekkers at Everest Base Camp is 51% vs.53% respectively (15).  
However, it has been reported that women have a slightly greater risk for AMS when 
pregnant or taking oral contraceptives (10). In contrast, one study shows AMS to be 
significantly more frequent in males than in females, 27.9% vs.23.6% at intermediate altitude 
(11) and 69% vs. 57% at 5400 m above sea level (23).  In general, most articles indicate that 
there are most likely no substantial gender differences in susceptibility to AMS, but the 
conclusion is different in different study sites and with different study designs.  
Diseases and health behavior 
A good state of health is recommended before ascent high altitude areas (22). People with 
obesity, severe hypertension, lung diseases (11), severe heart disease and upper 
gastrointestinal tract bleeding are advised not to travel to high altitudes (22). Asthmatic 
subjects, however, are considered to be better at high altitudes (10;22). Getting a cold is 
regarded as dangerous when entering high altitude, as it will increase the risk of AMS (50;51). 
Three studies reported no effect of cigarette smoking (10;11;23) on the prevalence of AMS.  
Individual susceptibility 
Individual susceptibility to AMS is reported and discussed broadly (6;10;11), but it is still not 
clear which particular physiological or pathophysiological features are associated with an 
increased individual susceptibility to AMS. See more about individual susceptibility in the 
section below. 
4) Pathophysiology of AMS 
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 The exact pathophysiological process that causes AMS is still unclear, although signs and 
symptoms of AMS and HACE point to a process in the central nervous system as the target 
organ for the illnesses. AMS is caused by an early stage of brain swelling, which at a later 
stage will cause HACE (7;32;52-57).  
A pathophysiological model of AMS and HACE, frequently reported in the literature 
(56;58;59), is based on reaction to hypoxia. Hypoxia occurs often among unacclimatized 
arrivals to high altitude. Hypoxemia refers to a lowered oxygen level in the blood, and AMS 
will easily develop (3). Hypoxemia causes brain edema and neuro-humoral and hemodynamic 
reactions that finally lead to a rise in the cerebral blood flow, altered permeability of the 
blood-brain barrier (BBB), and cerebral edema, as indicated in Figure 6. These changes result 
in brain swelling and raised intracranial pressure. According Hackett (58) and Roach (59), 
AMS may occur in persons who have inadequate cerebrospinal capacity to buffer the brain 
swelling; people with a larger ratio of cranial cerebrospinal fluid to the brain volume are 
better able to compensate for the swelling by displacement of cerebrospinal fluid. This 
hypothesis could explain the individual susceptibility of AMS, but it still remains speculative.  
 
Figure 6.  Proposed pathophysiology of AMS and HACE (Adapted from Basnyat B., Murdoch DR. High-
altitude illness (4))   
 
Other possible pathophysiologies of AMS, HACE and HAPE are also mentioned in older 
literatures (54;60-62), but all of them are still hypothetical. Even MRI findings among 
patients with HACE show changes are consistent with vasogenic edema (5;55), which has 
also been shown in animal studies (4). More research on the AMS mechanism should be done. 
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 5) Prevention of AMS 
Acclimatization serves to increase the delivery of oxygen to tissue, which is best achieved by 
gradual ascent (3;25). An ideal ascent rate is difficult to give and varies from person to person 
(4). Slower ascent may be necessary for some people, but not to all. A good recommendation 
about acclimatization and rates of ascent is the following: above 3000 m an increase in 
sleeping altitude should not extend 300 to 600 m per day and a day’s rest is recommendable 
for every 1000 meters of elevation gained; flying or driving directly to high altitudes should 
be avoided if possible. If symptoms of AMS occur and the state of health deteriorate, one 
should delay further the ascent or descend promptly. As AMS is worse during night (3;25), it 
is also advised to climb high but sleep low. 
Generally, acclimatization takes one to three days, but the rate varies for different people. Full 
acclimatization takes considerably longer time. No reliable predictors for easy acclimatization 
exist, except that people tend to be consistent in how well they acclimatize on different trips.  
In addition, in terms of existing individual susceptibility to AMS, a previous experience of 
AMS is the strongest indicator that it will be repeated during subsequent exposures to similar 
altitude at a similar ascent rate (4;32). 
Drug treatment before ascent may also be used as prophylaxis against AMS.  Acetazolamide, 
Dexamethasone and others have been recommended for people susceptible to AMS in the 
western world as have some traditional Chinese and Tibetan medicines which are used a lot 
by Chinese visitor to Tibet.  However, the effectiveness and required doses of Acetazolamide 
and other medicine are still not very clear (63-66).  Rhodiola Rosea  (Hong Jing Tian “红景
天” in Chinese and “Solo Marpo” in Tibetan) capsule is one of most popular traditional 
Chinese or Tibetan medicines to prevent AMS, even if in Tibetan medicine Solo Marpo has in 
the past not used on its own, but only in compounds. Solo Marpo positive effect in the 
prevention of AMS or in improving the AMS symptoms is confirmed in several studies (67-
69).  
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 6) Treatment of AMS 
Generally, treatment of AMS depends upon the severity of the symptom and, especially in 
mild cases, on patients’ preference. Mild cases can be treated conservatively, which means 
that the patients should avoid further ascent, limit physical activity, rest more and take 
adequate fluid (9) as well as that he or she should abstain from all alcoholic beverage and 
shall seek further care if symptoms get worse. Moderate to severe symptoms may require 
medication for symptomatic treatment such as against headache, nausea and vomiting, 
possibly supplemental oxygen and occasionally require descent. Because of the danger of 
exacerbating hypoxemia during sleep, avoidance of sleeping medication is suggested (70). 
Descent is always an effective treatment for AMS and in the wilderness; a portable hyperbaric 
bag may be used as an alternative to descent. Supplemental oxygen will certainly reduce 
hypoxia.  
AMS patients must be carefully monitored for any sign about whether the illness is 
progressing. If symptoms worsen patients need to descend immediately. Subtle changes such 
as irritability, lethargy, diminished performance, and shortness of breath at rest should also be 
taken as signs that the patient might be progressing towards HACE or HAPE. 
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 3. Aim and research objectives 
The main aim of the current research is to estimate the prevalence of AMS among tourists 
above fifteen years old in high altitude. 
 
Specific objectives 
1. To estimate the prevalence of acute mountain sickness among tourists above fifteen 
years in Lhasa, Tibet. 
2. To estimate the prevalence of acute mountain sickness in subgroups of the tourist 







A cross-sectional study was conducted among tourists above fifteen years of who stayed in 
selected hotels in Lhasa, during the research period from 2nd of June to 31st of October 2010.  
 
2. Population 
The study population were tourists above fifteen years old in Lhasa.  
The definition of a ‘tourist’ varies according to context. According to the United Nation 
World Tourism Organization in 1995, tourists are people who “travel to and stay in places 
outside their usual environment for more than twenty-four hours and not more than one 
consecutive year for leisure, business and other purposes not related to the exercise of an 
activity remunerated from within the place visited” (71). In our study, we included the 
following question from the questionnaire: “Do you consider yourself to be a tourist on the 
present travel to Lhasa,” in order to distinguish between tourists and other travelers. 
 
3. Recruitment 
The current study was carried out at hotels in the Cheng Guan District in the center of Lhasa, 
where most hotels are located (Figure 7). All selected hotels where the research was carried 
out are located in the main tourist zone in Lhasa. 
We used a simple cluster random method to select the sample. We randomly selected nine 
hotels from high, middle and low standards, where we then we inviting tourists who stayed 
there to particpate.  
Based on general hotel ratings we defined a high-level hotel as having a minimum of four-
stars; mid-level hotel as distinguished by two and three stars and low-level hotel as featuring 
one-star.
  
Figure 7.  Map of Lhasa city with research hotels-marked in yellow. (Adapted from Tibet travel information: http://www.tibettravel.info/images/map/map-of-lhasa-
x.jpg )
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 Since there are more rooms in high-level hotel and fewer rooms in low-level hotels, we 
randomly selected more low level hotels than high level hotels from the official list of hotels 
in Lhas. Of a high-level hotels, the Lhasa Manasarovar Hotel and the Jodan Secret Hotel (two) 
were selected from the official list of hotels in Lhasa, of mid-level hotels the Lhasa Gorkha 
Hotel, the Yak Hotel and the New Mandala Hotel (three) were selected and of low level hotels, 
the Lhasa International Youth Hostel, the Dongcuo International Youth Hostel, the Cool Yak 
Hotel and Old Mandala Hotel (four) were chosen. 
The Jordan Secret Hotel refused to participate immediately after we invited them. After one 
month of the data collection period, the three-star Yak Hotel and one-star Dongcuo 
International Youth Hostel withdrew from the project and we did not receive questionnaires 
from the high-level Lhasa Manasarovar Hotel. Thus, from 2nd of July 2010 onwards, the study 
was conducted in the remaining five hotels. (See Figure 8.)  
The criteria for inclusion and exclusion for the study were the following: 
1) Inclusion criteria   
 Check in at the selected hotels during the study period; 
 Ability to read and understand a Chinese or English version of the questionnaire; 
 Age above fifteen years; 
2) Exclusion criteria   
 Travelling to Tibet as non-tourist. 
 
Figure 8.  Final sample and the number of questionnaires received from the hotels from  June 2 to  
October 31, 2010. (Int. Youth Hostel: International Youth Hostel.) 
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 4. Data collection  
During the research period, we distributed 4000 questionnaires to eligible participant who 
stayed in the randomly selected hotels. 
1) The questionnaire  
We developed a questionnaire for the study, which followed the Lake Louise Scoring System 
(LLSS) which has been described earlier in this thesis. The questionnaire was tested in a pilot 
study in 2008 and the a revised version version was developed based on the experience gained 
during the pilot (24). 
The questionnaire has two pages, consisting of a total of 32 questions, which had been 
divided into eight main categories boxes. Box C of the questionnaire includes the Lake Louise 
questions on AMS (5 questions) (For details, see Appendix 1). The remaining questions 
provide general background information (age, gender, education, nationality, altitude of 
permanent residence, height, weight), way of transport to Lhasa, previous experience at high 
altitude, help seek due to AMS symptoms, health status, smoking habits, utilization of 
counter-high altitude sickness medicine, awareness of altitude sickness, activity after arriving 
in Lhasa and earlier exposure to altitude. 
The questionnaire on AMS itself in our questionnaire is identical to the one originally devised 
by the LLSS in English. We also applied a Chinese translated version for the Chinese 
speaking participants in the study. We translated the original English version into Chinese, 
and back translated to English to check for translation errors. Our Chinese translation was 
also adjusted to the original Chinese translation made by the Chinese Medical Association 
and Wu Tianyi from the National Key Laboratory of High Altitude Medicine in China, 
Qinghai University.  
2) Training of field workers  
We recruited eight fourth-year grade students from Tibet University Medical College (TUMC) 
and one to two receptionists from each hotel to assist the research.  
Half-day training was given to all hotel receptionists, regarding how to distribute and collect 
questionnaires and how to record them in the registration book. The training took place at 
Tibet University Medical College.  
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 Half-day training was also given to all student research assistants, regarding the research 
purpose and the questionnaire distribution and data collection procedure. All students were 
Tibetans, capable of speaking and writing both Tibetan and Chinese, and with a background 
in medical training covering basic research methods. A teacher from TUMC supervised them 
closely in how to distribute and collect questionnaires in hotels during the first week, and then 
more sporadic supervised them during the first month.   
Labasangzhu, the main researcher of the study, followed the students and the teacher during 
the last week of June, and then took over the work from 2nd of July to end of October, 2010. 
3) Procedure for the distribution of questionnaires  
The receptionists we have trained distributed the questionnaires to all tourists in their hotels. 
The distribution procedure (for details, see Appendix 4) depended on the length of the guests’ 
stay in the hotel: 
 If tourists planned to stay four nights or more, the questionnaire was delivered the 
third night after arrival. 
 If tourists planned to stay two or three nights, the questionnaire was delivered on the 
day before they checked out. 
 If tourists planned to stay only one night, the questionnaire was delivered at check-in 
time. 
 If tourists, for any reason, stayed shorter than initially planned, then it was attempted 
to make them hand in the questionnaire before they left. 
4) Collection of questionnaires   
Good rapport was built between the main researcher and his research assistants. Feedback 
about the research was directly given to researcher by call or face-to-face communication.  
Empty questionnaires, both English and Chinese versions, were sent to hotels once a week 
and kept at reception. Completed questionnaires were collected every day and checked for 
completeness and errors. The number of completed questionnaire was checked against the 




 5) Payment for data collection 
All research assistants including hotel receptionists and students were paid for their work. 
Three Chinese Yuan (CNY) were paid to the receptionists for each questionnaire collected in 
addition to a basic allowance per month, which was CNY 500 at high level hotel, CNY 300 at 
mid-level hotels and CNY 200 at low level hotel. All students were paid CNY 200 per student, 
plus a transportation fee and expenses for phone call for their work were paid for the period 
between 2nd of June to 31st of October 2010. 
 
5. Data entering  
A codebook was created and data from the questionnaire was entered into Statistical Package 
for Social Science (SPSS 15.0 version IBM, Chicago, IL, USA) by the author and the author’s 
colleague in December 2010. 
Data was cleaned under the guidelines of the Predictive Analytics Software statistics 18.0 
(PASW18.0) from 11th of January to 15th of February 2011. The data was checked for double 
recordings and odd values. 
 
6. Study variables 
AMS was the main variable under study. AMS according to the LLSS is based on five 
different symptoms, which include the following: 
a. Headache 
b. Gastrointestinal symptoms 
c. Fatigue and/or weakness 
d. Dizziness or lightheadedness 
e. Difficulty of  sleeping or insomnia 
Each symptom was ranked from 0 to 3 based on intensity levels of absence of symptoms, 
mild, moderate and severe symptoms.  
In the present study, the Lake Louise Scoring System (LLSS) was used. The definition 
(Appendix 1) of AMS mainly used was as follow:  
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 i. the presence of headache in an unacclimatized person who has recently arrived at 
Lhasa (3649 m), Tibet; 
ii. Plus the presence of one or more of the following symptoms: gastrointestinal 
symptoms, fatigue and/or weakness, dizziness/light-headedness, insomnia and,  
iii. Lake Louise scores at least three (≥3). 
To be able to compare with reported prevalence of AMS from other studies, we also applied 
the following two definitions:  
a. AMS defined as Lake Louise scores at least three (≥3), independent of having a 
headache or not. 
b. AMS defined as presence of headache plus one of the other symptoms and a Lake 
Louise score of at least four (≥4).   
We estimated the prevalence of AMS in subgroups of the population. The following variables 
were used to define the subgroup, as shown in Table 7.  
English and Chinese language questionnaires were available in the present study. The 
prevalence of AMS was presented separately for participants answering the English and 
Chinese version of the questionnaire. 
Age was reported in years converted into a categorical variable (15 to 19 years: adolescence; 
20 to 40 years: young adult; 41 to 60 years; middle aged; more than 60 (>60) years: elderly). 
Education level was categorized into “some high school education(attended some high school 
but did not graduate)” , “high school education (graduate with high school diploma)” , “some 
college education (attended some college but did not graduate)”  , and “university or higher 
education” .  
We used two categories of residential altitude: 2000 meters or higher (>6500ft) and below 
2000 meters (<6500ft).  
Weight was reported in kilograms or pounds and height in centimeters, feet, and inches. The 
reported information was converted to kilograms for weight and centimeter for height. BMI 
was calculated and categorized according to the World Health Organization (WHO) definition 
of Body Mass Index (BMI) (kg/m2) (Table 6). 
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 Table 6. The international classification of adult underweight, overweight and obesity 
according to body mass index (BMI) 
Classification Principal cut-off points of BMI(kg/m2) 
Underweight <18.50 
Normal range  18.50 - 24.99 
Overweight ≥25.00 
Obese ≥30.00 
Source: Adapted from WHO, 1995, WHO, 2000 and WHO 2004. 
 
Three options were listed in the questionnaire for the way of transport used by the tourists 
when arriving in Lhasa:  airplane, train and car or bus. An extra category had to be added as 
there were tourists that reported arrival by bike or by foot. 
General state of health means the state of health before arriving Lhasa. This was a question 
requiring self-report with answers such as poor, not very good, good or very good.  
Health problem was taken to mean whether the participant had been diagnose with a disease 
by a doctor.  
Whether the subject took medication to prevent AMS was an ‘yes or no’-question followed by 




 Table 7.  Operationalization of variables 
Variable Scale Coding  Remark  
Headache;  
Categorical
0=No headache  1=Mild headache 
2=Moderate headache 3=Severe headache, incapacitating  
Gastrointestinal symptoms;  
Categorical
0=No gastrointestinal symptoms  1=poor appetite or nausea 
2=Moderate nausea or vomiting  3=Severe nausea or 
vomiting  ,incapacitating 
 
Fatigue and/or weakness;  
Categorical
0=No tired or weak  1=Mild fatigue/weakness 





0=Not dizzy 1=Mild dizziness 
2=Moderate dizziness 3=Severe dizziness, incapacitating  
Difficulty sleeping  
Categorical
0=Sleeping as well as usual  1=do not sleeping as well as usual   
2=Woke us many times, poor night’s sleep  3=Could not sleep at 
all 
 
Questionnaire Language Categorical 1=English  2=Chinese  
Age Continuous >=15 years 
Converted into categorical variable as 
Age group: 1=15 to 19; 2=20 to 39;  
3=40 to 60;  4= more than 60. 
Gender Categorical 0=female  1=male  
Nationality Categorical
1=Chinese; 2=American; 
3=Spanish; ……  48=Latvian 
 
Level of education Categorical
1=<some high school  2= high school 
3=some college 4>=University/master 
some high school/college 
education(attended some high 
school/college but did not graduate) 
Altitude of permanent 
residence 
Categorical
1=2000 meters or higer (>6500ft) 
2=< 2000 meters (<6500ft) 
 
Weight Continuous Self-reported weight in Kilograms /pounds  
Height Continuous Self-reported height in Centimeters /feet/inches 
Converted into categorical with body 
mass index(BMI) 
Tourist Categorical 0=no    1=yes  
Date of arriving date Day/month/year  
Transportation to Lhasa Categorical
1=by airplane 2= by train 3=by car/bus 
4=by bike    5=by foot 
 
Previous experience in 
high altitude area 
Categorical 0=no   1=yes  
Self-reported reason for 
AMS symptoms 
Categorical 0=no   1=yes Food and drink/high altitude/other 
If get help in Lhasa Categorical 0=no  1=yes Doctor/nurse at hotel and to hospital 
Diagnose AMS Categorical 0=no  1=yes   2=  I do not know  
Health status  Categorical
1=poor  2=not very good 
3=good  4=very good 
 
Health problem Categorical 0=no 1=yes 
Diabetes/hypertension/Cardiovascular 
diseases/asthma 
Smoking habits Categorical 0=no 1=yes  
Pregnant Categorical 0=no 1=yes  
Contraception Categorical 0=no 1=yes  
Medicine to prevent AMS Categorical 0=no  1=yes  
Fluid intake 24 hour before 
and after in Lhasa 
Categorical
1=Less than normal 
2=Normal 
3=More than Normal 
 
Pain-reliving medicine use Categorical 0=no 1=yes  
Awareness of AMS before 
arriving in Lhasa 
Categorical 0=no 1=yes  
Physical exercise after in 
Lhasa 
Categorical 0=no 1=yes  
Experience of AM before 
this time in Lhasa 
Categorical 0=no  1=yes   2=never been at high  
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 7. Statistical methods  
The prevalence of AMS was estimated among a the total sample and in a subset of the sample 
where we had a high response rate (which means in two hotels during a limited time period)  
(Table 8 and 11).  
The subgroups set according to the risk factors or protective factors report in previous study.  
Chi-square (χ2) tests were applied for comparing differences in prevalence between subgroups 
of the population. 
Level of statistical significance was set to ≤0.05 and/or 95 percent confidence interval 
(95%CI). 
Predictive Analytics SoftWare 18.0 was used for statistical analysis. 
 
8. Ethical considerations 
All research process strictly followed the World Medicine Association Declaration of 
Helsinki the 59th  General Assembly in 2008 (72). 
Participation was voluntary and anonymous with no name or identity written on any research 
documents.  
1) Benefits to participants in the study 
Participation in the study may not have benefited the participants directly, but the study has 
probably raised the tourists’ awareness about AMS. It may lead to future better understanding 
of AMS, which will have an overall positive effect on travelers to high altitude areas in the 
world. 
2) Risks 
This study posed no known risk to its participants. The information collected was considered 
only marginally sensitive and participants were informed of their right to choose not to 
answer any questions that may have made them uncomfortable. There was no risk of physical 
injury in the participation of the survey. 
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 3) Confidentiality 
The questionnaire was entirely anonymous and there was no physical contact between 
researcher and subjects. Therefore the confidentiality of subjects was guaranteed to a great 
extent.  
4) Ethical approval 
Prior to data collection, in May 2010, the study protocol was submitted to the Norwegian 
National Committee for Medical and Health Research Ethics to receive official ethical 
clearance approval from their committee. However, the committee found the study 
unnecessary to undergo evaluation.  
We attached information about the study on each questionnaire, and participants were asked 
to read it carefully before deciding whether to participate or not.  
 
9. Communication of results 
The present thesis will be published through the DUO system of the University of Oslo (UiO), 
Norway. At a later stage, the aim is try to publish the findings in international peer-reviewed 
journals.  
The author and colleagues plan to present a summary of the study to the health and tourism 







1. Response rate 
Altogether 4000 questionnaires were distributed and 2385 were returned, which means a 
return rate of 60%. Among those that were returned, 106 people stated they refused to 
participant and 104 of these also stated their reason. The lack of understanding either Chinese 
or English and time limitation were main reasons. Nine questionnaires were considered 
unreliable because they featured the same handwriting as another questionnaire; 30 
questionnaires were filled in incompletely; ten were answered by tourists less than fifteen 
years of age and 27 were answered by non-tourists. Therefore, 2203 questionnaires out of 
4000 were used in data analysis, giving the study a response rate of 55.1%. 
The response rate varied between hotels and over the time period. The response rate during 
July and August in the New Mandala Hotel and between the 18th of August and the 29th of 
October in the Old Mandala Hotel was 86% and 73% respectively (Table 8). The total 
response rate in the two hotels’ reached to 79%. 
 
Table 8.  Response rate in the Old Mandala Hotel and the New Mandala Hotel in Lhasa 







Old Mandala Hotel 18 Aug-29 Oct 642 340 291 86 
New Mandala Hotel 2 Jul-30Aug ---**** 350 252 72 
Total 642+? 690 543 79 
* Number of guests who were registered on hotel register book.  
** Number of questionnaires received from tourists. 
***Number of questionnaires distributed to tourists. 
 **** Data are not available in from New Mandala Hotel. 
 
 
The results of this study will be presented in the following order below: Demographic 
characteristics, Prevalence of AMS, and Prevalence of AMS in subgroups. 
2. Socio-demographic characteristics 
Socio-demographic characteristics of gender are presented in Table 9.   
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Participants ranged in age from 15 to 81 years and the mean age was 37.2 (36.9 for females 
and 37.7 for males). Most participants (61.1%) were in the 20 to 40 age group, and only 3.9% 
in the age group 15 to 19. 65.5% of the participants had obtained university or higher 
education, while only 4% had some high school education but not graduated or they were still 
studying in high school. More than one third of participants stayed in middle level hotels and 
the remaining lived in low level hotels. Most of participants were low altitude dwellers, only 
5% had residence at 2000 meters or higher areas. More than half of participants filled in 
English questionnaires.  
 
Table 9. Socio-demographic characteristics among tourists above 15 years old in Lhasa 
Characteristics     Women, N(%)*  Men, N(%)*  Total, N(%)*
Age group   
15-19 46 (4.1) 39 (3.6) 85 (3.9)
20-40 686 (61.7) 656 (60.5) 1342 (61.1)
41-60 274 (24.6) 270 (24.9) 544 (24.8)
Older than 60  106 (9.5) 119 (11.0) 225 (10.2)
  
Mean Age (years)  36.9 37.7 37.2
  
Education   
Some high school  47 (4.3) 44 (4.2) 91 (4.2)
High school 142 (13.0) 131 (12.4) 273 (12.7)
Some College  212 (19.4) 173 (16.4) 385 (18.0)
University or higher 689 (63.2) 705 (67.0) 1394 (65.5)
 
Hotel   
Middle Level Hotel 401 (36) 379 (35) 780 (35.5)
Low Level Hotel 713 (64) 703 (65) 1416 (64.5)
Language of questionnaire   
English 594 (53.4) 597 (55.1) 1191 (54.2)
Chinese 518 (46.6) 487 (44.9) 1005 (45.8)
 
Altitude of permanent 
residence/home  
 
2000 meter or higer (>6500ft) 48 (4.5) 65 (6.2) 113 (5.3)
Below 2000 meters(<6500ft) 1023 (95.5) 984 (93.8) 2007 (94.7)
        * Number of participants (%).  
 
Tourists from 48 different countries participated in the study and of which Chinese tourists 
were the largest group of participants numbering 1023 (46.9%), followed by 138 (6.3%)Dutch 
with, 126 (5.8%)the Americans, 106 (4.8%) the Germans, 82 (3.7%) the French, and 80 (3.7%) 




Figure 9. Number of participants and their nationalities  
(1023 Chinese participants not included; Unknown: the name of the country is not on the world countries list.) 
 3. The Prevalence of AMS 
In the total sample (n=2203), the prevalence of AMS was estimated to 50.8%, while in the 
subgroup of the two hotels (n=543) was 44% according to the Lake Louise scoring system 
(LLSS) AMS diagnosis standard (headache plus one of other symptoms and Lake Louise 
score (LLS)≥ 3) (Table 11).   
Base on the AMS definition: headache plus one of other symptoms and LLS≥4, the 
prevalence dropped to 36.7% in the total sample and 35.2% in the two hotels sample (Table 
11).  This definition indentifies more severe cases. 
Using the AMS definition LLS≥ 3, without requirement of headache being a symptom, the 
prevalence increased to 58.5% in the total sample and 53.1% in the two hotels sample. 
The study did not aim at identifying cases with the more severe conditions HACE and HAPE, 
but based on personal communication with a doctor in the ‘First TAR People’s Hospital’, at 
least two person from Lhasa Gorkha Hotel in August 2010 were urgently sent back to low-
land by plane due to HACE or HAPE.  
 
Table 10.Prevalence of acute mountain sickness (AMS) in tourists above 15 years of age 
in Lhasa, Tibet 
 The 2203 Sample                   
 (The Whole Sample) 
 The  543 Sample 
               (The Two Hotels’ Sample)   AMS definition 
   Responders Prevalence% (95% CI) Responders Prevalence% (95% CI)
       
Yes  1107 50.8  (49–53) 239 44  (40– 48 )AMS LLS standard  
 (Headache is compulsory) LLS*≥3 No 1070 49.2 304 56
   
Yes  748 36.7  (34.6–38.8) 184 35.2 (31.1–39.3)AMS LLS standard  
 (Headache is compulsory) LLS* ≥4 No 1288 63.3 399 64.8
   
Yes  1224 58.5  (56–61) 286 53.1  (49–57)AMS LLS*≥3  
(Headache is not compulsory) No 867 41.8 253 46.9
      






4. Symptoms of AMS 
82% of participants reported symptoms of AMS in the total sample. The most common of the 
five AMS symptom was fatigue and/or weakness (66.8%), while the least common was 
gastrointestinal symptom (25.6%) . The symptom insomnia had the largest percentage of 
severe condition (3.4%) (Figure 11).  
For almost half of the participants who suffered from AMS, the onset of symptoms occurred 
within the first twelve hours after arriving in Lhasa. 15.3% of the participants with AMS 
symptoms the onset of symptoms was between 12 and 24 hours; and 3.8% between 24 and 48 
hours and after 2.8% after 48 hours. Moreover, 30.5% of participants suffered from the AMS 
symptoms before they reached hotels in Lhasa.  Among them, 60.1% took train to Lhasa, 
22.1% by air (including the road by car from airport to Lhasa), and in 17% by car or bus. 
The results were similar in the two hotels sample regarding the symptoms of AMS.
  
 
Figure 10. Symptoms prevalence (%) of acute mountain sickness in the total sample (n=2203)
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5. Prevalence of AMS in subgroups of the population 
In table 11, we present the prevalence of AMS in subgroups of the population. 
The AMS prevalence among participants with previous experience at high altitudes was 
significantly lower than in those without previous experience. 
The prevalence of AMS in people aged at 20 – 40 and 40 – 60 was significantly higher than in 
younger and elder age groups.   
Men had significantly higher AMS prevalence (53.4%) as compared to women (48.4%). 
AMS among participants who arrived to Lhasa by air was significantly more common than 
among those arrived more gradually by bus or car.  
The AMS among participants with previous AMS symptoms experience were significantly 
higher than those have not suffered from AMS symptoms. 
The prevalence of AMS among smokers were significantly lower than non-smokers (p<0.05).   
 
The AMS prevalence differs across countries, but care should be taken due to low members 
for some of the countries, especially among these with high or low prevalence (Figure 11).   
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 Table 11.  Prevalence of AMS in subgroups of the population of tourists above 15 years old 
visiting Lhasa, Tibet 2010 
 
Characteristics  Responders*           AMS***, n (%)***               p value 
Questionnaire language  
English 1175 578 (49.2) 0.094
Chinese 1002 529 (52.8) 
 
Gender  
Male 1104 590 (53.4) 0.019
Female 1068 517 (48.4) 
 
Age group  
15-19 86 36 (41.9) 0.003
20-40 1334 703 (52.7) 
41-60 532 276 (51.9) 
Older than 60 225 92 (40.9) 
 
Education  
Some high school 90 44 (48.9) 0.641
High school 270 129 (47.8) 
Some College 380 195 (51.3) 
University or higher 1385 718 (51.8) 
 
Altitude of perminient residence  
Below 2000 m 1993 1024 (51.4) 0.077
2000m or higher 110 47 (42.7) 
 
Previous experience at high altitude  
Yes 553 206 (37.3) <0.001
No 1611 894 (55.5) 
 
Hotel  
Middle Level Hotel 769 408 (53.1) 0.242
Low Level Hotel 1398 705 (63.3) 
 
Transportations to Lhasa  
By air 1023 557 (54.4) 0.001
By train 944 469 (49.7) 
By bus/car 190 75 (39.5) Cont.
* Numbers of total respondents to those items. 
** Acute Mountain Sickness.  
*** Numbers of total respondents to those items and percentage. 
 p< 0.05; 
51 
 Tabel 11 cont. Prevalence of AMS in subgroups of the population of tourists above 15 
years old visiting Lhasa, Tibet 2010 
 
Characteristics Responders*           AMS***, n (%)***               p value
BMI classifacation 
Underweight 189 85 (45.0) 0.316
Normal 1430 745 (52.1)
Overweight 392 197 (50.3)
Obese 119 60 (50.4)
 
Lung diseases  
Yes 36 22 (61.1) 0.24
No 2067 1059 (51.2)
Asthma 
Yes 54 24 (44.4) 0.306
No 2045 1053 (51.5)
Cardiovascular diseases  
Yes 26 14 (53.8) 0.787
No 2069 1059 (51.2)
Hypertension 
Yes 113 55 (48.7) 0.997
No 1982 1017 (51.3)
Diabeties  mellitus 
Yes 30 14 (46.7) 0.605
No 2075 1067 (51.4)
 
Smoker 
Yes 251 110 (43.8) 0.013
No 1847 964 (52.2)
 
Preganancy 
Yes 8 4 (50) 0.884
No 1105 581 (52.6)
 
Awareness 
Yes 1850 953 (51.5) 0.387
No 247 120 (48.6)
 
Previous AMS symptoms 
Yes 589 302 (51.3) <0.0001
No 1010 470 (46.5)
Never been at high altitude 463 284 (61.3)
* Numbers of total respondents to those items.   
** Acute Mountain Sickness.  
*** Numbers of total respondents to those items and percentage. 




Figure 11. AMS prevalence in tourists according to country  
(* The name of the country is not on the world countries list.) 
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 6. Self-reported Causes of AMS Symptoms  
Among the participants with the AMS symptoms (m=1572), 87.4% reported that the high 
altitude was the cause of the symptoms, and few (9.5%) believed that the bad quality of food 
or water in Lhasa was the cause of the symptoms, and the remaining of the participants 
thought that their symptoms were due lack of enough rest; weather; bad trip plan; jet lag; and 
poor hotel conditions such as hard mattress and noisy environment.  
 
7. Awareness of AMS  
88% of participants were aware of AMS before they travelled to Lhasa. The awareness was 
obtained through various information sources. Internet was the most used for obtaining AMS 
knowledge, followed by friends or colleagues or family members, travel guidebooks, travel 
agencies, doctors, other health personnel’s and other (Figure12). 
 
Figure 12. Source of AMS related information among the 2203 participants (numbers of people) 
 
 
8. Prevention and Help Seeking 
Almost half of the participants (n=965) took prophylactic medication to meet the high altitude. 
Among them, 25.3% used Acetazolamide or Diamox, 72.6% took other medicine and 2.1% 
took Stteroids or Nifedipin.  88.7% of whom took other medicines chose traditional Chinese 
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 or Tibetan medicine Rhodiola (Hong Jing Tian “红景天” in Chinese and  “Solo Marpoin” in 
Tibetan) capsule and alike. Slightly more than one quarter took pain-relieving medication 
during the first 48 hours after their arrival in Lhasa.  
282 participants out of 1572 with AMS symptoms chose to seek help or advice during their 
stay in Lhasa. Among them, 20 (10.6%) received a visit by local doctor or nurse; 92 (32.6%) 
went to local hospitals or clinics; and 150 (53.2%) got help from others such as their tour 
companions or local Tibetan friends. Among those who had AMS symptoms, only 69 (4.7%) 





1. Overview  
For the first time this cross-sectional study has investigated the prevalence of acute mountain 
sickness (AMS) among domestic and international tourist groups in Lhasa based on the 
internationally accepted Lake Louise Scoring System (LLSS)-questionnaire.   
The main findings of the present study are that AMS prevalence in in the study group in 
Lhasa was 50.8% based on the whole 2203 sample and 44% in the subgroups of the two hotel 
specific samples. More than 80% of participants suffered from at least one AMS symptom 
during their stay in Lhasa. Fatigue and/or weakness and headache were the two most 
commonly experienced symptoms.  
2. Methodological consideration  
Biases occur in almost all epidemiological studies and the present study is no exception in this 
regard. Bias is defined as a “deviation of results or inferences from the truth, or processes 
leading to such deviation” (73).  Biases occur in the collection, analysis, interpretation, and/or 
review of data that can lead to conclusions that are systematically different from the truth (73). 
A biased study loses the validity of its result. It is difficult or even impossible to completely 
eliminate bias, but it is very important to minimize biases as much as possible with well-
designed and well-conducted research. Moreover, it is crucial to check if results could be 
biased and then to draw conclusions accordingly.  
In this methodological discussion, potential methodological problems in the study design, 
sample selection and information from participants will be discussed. 
1) Study design  
Following the aim of the present study, to estimate the prevalence of AMS, we designed a 
cross-sectional study.  
In addition, to estimate the prevalence of diseases and determinants, a cross-sectional study 
examines the relationship between diseases and other variables of interest (73). Since one 
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 cannot be sure if the factors or exposures preceded the health outcome in a cross-sectional 
study, the study can hardly offer evidence of causality (74). Nevertheless, a cross-sectional 
study estimates the prevalence of diseases (74), and that is the main aim of the present study 
was to investigate the prevalence of AMS.  
To assess the AMS, the Lake Louise Score System (LLSS) has been used in the present study. 
Using LLSS makes it possible to compare our results with other studies because LLSS is 
internationally recognized and is the most used form to assess the occurrence of AMS 
(38;75;76). LLSS has been validated in numerous studie, the Lake Louise questionnaire is 
simple and effective (76;77), a short and simple questionnaire was considered to be important 
to get as many as possible of tourists in the hotels to paricipante  in the study.  
2) Selection problem 
Selection problems here mainly refer to selection biases, which is an error because of 
systematic differences in characteristics between those who take part in the study and those 
who do not. Selection bias invalidates conclusions and generalization that might otherwise be 
drawn from the study (73).  
One of the strengths of the present study is that the study hotels were randomly selected based 
on a hotel list given by the Chengguan District Tourism Bureau. However, we lack 
information from high-level hotels and it is not possible to know if this has led to bias in the 
results. Moreover, many tourists refused to participate due to various reasons such as time 
limitation, too long questionnaire, that could not understand an English and Chinese 
questionnaire or just because they have not suffered from AMS symptoms. In addition, it is 
likely that tourists with serious symptoms did not answer the questionnaire, which would lead 
to an underestimation of the prevalence of AMS.  
In order to increase the response and, thus, to minimize the selection bias, the researcher 
stayed in the reception two to three hours every day to supervise research assistants’ work. 
Overall, selection bias may exist in the study; however, we did our best to avoid the bias, such 
as training research assistants and hotel receptionists and staying in hotels with hotel staffs.   
We aimed at a high number of participants to allow for large variation in characteristics of 
tourists for subgroup analysis and to cover most of the tourist season. We distributed 4000 
questionnaire from June to October and totally 2385 questionnaires returned (60%) and 
finally 2203 questionnaires analyzed, giving a response rate of 55.1%. The sample size is 
much larger than most previous similar studies, but it is known from previous studies that low 
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 response rate may hamper prevalence estimates (78). We compared the prevalence estimate 
with a subset from ‘two hotels’ sample, including 543 participants with a response rate 79%.   
The question that arises then is whether the total of 2203 with a response rate of 55.1% or the 
subset with a response rate of 79% shall better represent the total tourist population of Lhasa.  
As we know surveys with high response rates yielded more accurate estimates than did 
surveys with lower response rates (79), the 543 sample, which were collected from one 
middle level hotel and one low level hotel should be better to estimate the prevalence. 
However, the sample is smaller than and perhaps not as representative as the total samples. 
The prevalence of AMS was 50.8% in the total sample and 445 in the subset. It is known from 
previous studies that non-response in higher among individuals with health problems (78), 
thus, we have an opposite situation in the present study. Based on our findings we could say 
that the prevalence of AMS among tourists in Lhasa is high, and between 44–50.8% and it is 
not known if it is an overestimate or underestimate.  
3) Information problems 
Information error could result in incorrect prevalence estimates (80).  If the criteria for AMS 
are not valid in a way that if either systematically overestimate or underestimate symptoms of 
AMS. Also there will be incorrect estimate if there is a symmetric allocation of those with 
AMS by subgroups we were comparing.  
Questionnaire was the tool to collect data in this study. Generally, the information on the 
questionnaire was straightforward and easy to understand. A pilot study was done to ensure 
that the questionnaire was correct illustrated and Chinese questionnaire was back translated 
into English and adjusted by the Chinese version previously used by National Key Laboratory 
of High Altitude Medicine in China.     
One potential problems could be that tourists not really good in English or Chinese may have 
misunderstood questions. Although it is a large variation in AMS prevalence between 
nationalities of the tourists, such errors should not be symmetrically, and, thus, not affect the 
prevalence estimates. 
We used self-reported symptoms rather than objective clinical examination or diagnostic test 
to obtain data on AMS. Most symptoms of AMS are not very specific, whereas some are 
common after a long time travel and accommodation changes. This error may have led to an 
overestimates of AMS in the present study. 
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 In this study, the questionnaires were answered a short time after the subject’s exposure at 
high altitude areas; therefore, the recall bias could be minimal. Interview bias may exist due 
to our hotel receptionists. Because some receptionists may have preferred to deliver 
questionnaire to healthy and easy-going guests and avoid disturbing to guests with poor health 
condition during their stay in the hotel, leading to underestimation of AMS. However, it is 
difficult to know if this source of bias was significantly, as we have trained receptionists to 
best possible practice.  
 
3. Discussion of results 
1) The prevalence of AMS 
A total of 50.8% of tourists in Lhasa developed AMS based on the total sample, when defined 
as headache plus an additional symptom and LLS ≥ 3. The AMS prevalence in the Old 
Mandala Hotel and New Mandala Hotel in different time periods with 79% response rate 
amounted to 44% according to same diagnostic criteria. If 21% of guest who did not 
participate in the research developed AMS, then the prevalence would increase to 56%, 
alternatively, if all the 21% were free of sickness, the prevalence would drop to 35%. 
The AMS prevalence in the current study was much lower than the prevalence of 84% noted 
by Murdoch (1995) (49) among tourists flying directly to 3740 meters and sleeping at 3860 
meters altitude area. The difference in prevalence might be a result of increasing awareness of 
altitude-related illness among tourists as the study of Murdoch was conducted more than 15 
years ago. Another reason could be from using the different modes of flight in different 
studies: civil airplanes with pressurization were used to Lhasa, but helicopters were used to 
Shyangboche Hotel in Nepal Himalayas (49).  
Based on the same AMS definition: headache, an additional symptom and a Lake Louise 
scores at least four, the prevalence is quite similar among tourists in Lhasa (36.7% in the total 
sample and 35.2% in the two hotels’ Sample) and mountaineer and tourists in Eastern (38%) 
and Western (34%) Alps (16;17;69). Moreover, these two studies had a similar altitude with 
Lhasa and a similar response rate (Table 5). 
On other hand, though using different AMS definition, except for the study done in Nepal by 
Vardy  and his colleagues (48), in most studies, the prevalence of AMS ranged from 34% to 
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 57.2% at the altitude of 3000 to 4000 meters (14-17;20;22;76) (Table 5). This is quite similar 
to the findings of the present study.  
2) The prevalence in subgroups  
We support findings for several previous studies which reported that rapid ascent is a risk 
factor for developing of AMS (10;32;60). In this study we found that the prevalence of AMS 
was significantly higher among the tourists who flew or travel by train to Lhasa as compared 
with those who went by bus or car. Stepwise ascent is strongly recommended for when 
travelling to high altitude, but it is not very convenient to go by car or bus to Lhasa.  
Although individual susceptibility as risk factors to AMS is reported and discussed widely 
(6;10;11), the mechanism is still unknown. People who have a previous experience of AMS 
symptoms should be careful when they re-enter high altitude areas. In the present study, we 
found that the prevalence among tourists with prior AMS episodes had significantly higher 
AMS than those without high altitude experience. 
In adults, a decrease in AMS with increasing age (above 40) is reported among Himalayan 
trekkers (34), conference attendees  (11), mountaineers (15).  It seems that older persons may 
be less susceptible from AMS, but the reason is not known yet. The perception is that older 
people are more sensitive about symptoms of AMS and therefore are more careful about their 
health and less frequently ascend at very high altitude areas. In this study, tourists in age 20 to 
60 were more susceptible than those older than 60 years. It seems, thus, that the finding from 
this study agrees with previous studies. 
Poor health condition before entering a high altitude area has been reported as a risk factor 
(11;22). We found that the prevalence of AMS among people with a “poor or not very good” 
health condition before entering Tibet was significantly higher than those tourists with better 
health status. However, other diseases such asthma, diabetes, lung diseases overweigh or 
obesity did not affect the AMS prevalence, which is in accordance with previous studies 
(10;22).  
The prevalence of AMS was higher in the subgroup of tourist who lacked experience of high 
altitude as compared with that previous experience in last three months. It may be explained 
by the lack of awareness; however, analysis shown that the awareness among the participants 
reached to 88% among both with or without previous experience in high altitudes. Therefore, 
it could be that those with altitude experience in the last three months kept paths of the 
physiological adaption the established during their last visit. 
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Based on the total sample, the prevalence of AMS among male was significantly higher than 
among females, but the relationship was not found in the subset two hotels’ sample. Other 
studies have shown that the prevalence in men and women trekkers at Everest Base Camp is 
quiet equal, 51% and 53% respectively (10).  However, women have a slightly greater risk for 
AMS when pregnant or taking oral contraception (10). Another study, in contrast, shows 
AMS to be significantly more frequent in males than in females (27.9%vs.23.6%) at 
intermediate altitude (11) and (69% vs.57%) at 5400 m above sea level in Nepal (23).  In 
general, most articles indicated that there are most likely no substantial gender differences in 
susceptibility to AMS. 
It is recommended to reduce or quit smoking at high altitude areas, because of lower oxygen 
saturation. However, three studies reported no different in AMS prevalence between smoker 
and non-smoker (10;11;23). In contrast, the present study reports a higher prevalence of AMS 
in smokers than among non-smokers. The awareness among two groups was almost same, 
more than 80%.   
Taking medication aimed at preparing for meeting high altitude should reduce the prevalence 
of AMS; however, we found that the prevalence among those people was significantly higher. 
Those people had a higher awareness on AMS, but no difference on other characteristics. It 
could be that they have experienced AMS before, i.e. have a greater individual susceptibility 
to AMS. Further analysis must be conduct to test this hypothesis. It is also a discussion about 
lack of effectiveness of drugs they used.  
  
4. Conclusions 
The estimated prevalence of AMS among tourists in Lhasa is high and lies between 44%–
50.8% using the LLSS AMS diagnostic standards (headache plus one other symptoms and 
LLSS≥ 3).  It is more likely that we have underestimated than overestimated, because it is 
likely that a high proportion of tourists with AMS symptoms than without were among the 
responders. They may simply not manage to fill in the questionnaire due to headache and 
other AMS symptoms.  
The prevalence of AMS was significantly higher in people who rapidly ascend to Tibet, 
middle aged, without experienced at high altitude and experienced previous AMS symptoms. 
 
5. Future research and recommendations  
Data from the present study should be analysed, especially multiple regression analysis, and 
additional in-depth interview should be conduct to illustrate the acute mountain sickness risk 
factors.   
Due to change in the policy, foreign tourists are not allowed to enter Tibet alone, but only as a 
group under a guided of travel agency. The tour guide or travel agency could access foreign 
tourists better than hotels receptionist. Thus further studies on AMS among foreign tourists in 
Lhasa could be better performed if one could conduct a study based on randomly selected 
travel agencies.  
As winter Tibet trips have been introduced, one should conduct research in the winter season, 
as the climate may increase the risk of AMS (6;81), and the risk factor pattern may differ 
from the summer season.  
More tourists can be recruited if one could develop Spanish and French questionnaires.   
Having a good self-reported health condition before entering high altitude is recommended, 
and middle age people and people who have experienced AMS symptoms should pay more 
attention on the AMS.  
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 Information about the high prevalence of AMS, and the subgroups at high risk should be 
conveyed to doctors in those countries sending tourists to high altitude areas and tourist 
companies, and health and tourism authorities in Lhasa, Tibet. 
We aimed at preparing an information brochures and web-page to spread the knowledge to 
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